Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.

De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: A multicenter non-blinded randomized noninferiority trial.

Open access

Abstract

Background In patients with severe sepsis, no randomized clinical trial has tested the concept of de-escalation of empirical antimicrobial therapy. This study aimed to compare the de-escalation strategy with the continuation of an appropriate empirical treatment in those patients. Methods This was a multicenter non-blinded randomized noninferiority trial of patients with severe sepsis who were randomly assigned to de-escalation or continuation of empirical antimicrobial treatment. Recruitment began in February 2012 and ended in April 2013 in nine intensive care units (ICUs) in France. Patients with severe sepsis were assigned to de-escalation (n = 59) or continuation of empirical antimicrobial treatment (n = 57). The primary outcome was to measure the duration of ICU stay. We defined a noninferiority margin of 2 days. If the lower boundary of the 95 % confidence interval (CI) for the difference in patients assigned to the de-escalation group was less than 2 days, as compared with that of patients assigned to the continuation group, de-escalation was considered to be noninferior to the continuation strategy. Secondary outcomes included mortality at 90 days, occurrence of organ failure, number of superinfections, and number of days with antibiotics during the ICU stay. Results The median duration of ICU stay was 9 [interquartile range (IQR) 5-22] days in the de-escalation group and 8 [IQR 4-15] days in the continuation group, respectively (P = 0.71). The mean difference was 3.4…

Overview

Integrity signals

Registry

Crossref · 10.1007/s00134-014-3411-8

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 32 references

Cited by

See all 243

Metadata

Authors
Leone, M., Bechis, C., Baumstarck, K., Lefrant, J.-Y., Albanèse, J., Jaber, S., Lepape, A., Constantin, J.-M., Papazian, L., Bruder, N., Allaouchiche, B., Bézulier, K., Antonini, F., Textoris, J., Martin, C., & For the AZUREA Network Investigators
Affiliations
  • Hôpital Nord (FR)
  • Aix-Marseille Université (FR)
  • Centre Hospitalier Universitaire de Nîmes (FR)
  • Hôpital de la Conception (FR)
  • Inserm (FR)
  • Hospices Civils de Lyon (FR)
  • Centre Hospitalier Universitaire de Clermont-Ferrand (FR)
  • Centre National de la Recherche Scientifique (FR)
  • Hôpital de la Timone (FR)
Venue
Intensive Care Medicine
Published
2014-08-05
Volume
40
Issue
10
Pages
1399-1408
ISSN
  • 0342-4642 (ISSN-L)
  • 1432-1238
OpenAlex
W2053430308
Cited by
243
References
32
Citations by year
2026: 10 · 2025: 16 · 2024: 18 · 2023: 18 · 2022: 17 · 2021: 18 · 2020: 28 · 2019: 27 · 2018: 18 · 2017: 22 · 2016: 32 · 2015: 14 · 2014: 5
FWCI
18.32
Type
journal article
Language
en
Open access
Licence
Locations
  • Intensive Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
  • Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
Keywords
severe sepsis, antibiotic de-escalation, empirical antimicrobial therapy, ICU length of stay, superinfection, antibiotic duration, mortality, organ failure
MeSH terms
Aged, Anti-Bacterial Agents, Female, France, Humans, Intensive Care Units, Length of Stay, Male, Microbial Sensitivity Tests, Middle Aged, Multivariate Analysis, Linear Models, Proportional Hazards Models, Sepsis, Withholding Treatment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: A multicenter non-blinded randomized noninferiority trial. https://app.cochat.ai/papers/10.1007/s00134-014-3411-8
The paper
Leone, M., Bechis, C., Baumstarck, K., Lefrant, J.-Y., Albanèse, J., Jaber, S., Lepape, A., Constantin, J.-M., Papazian, L., Bruder, N., Allaouchiche, B., Bézulier, K., Antonini, F., Textoris, J., Martin, C., & For the AZUREA Network Investigators. (2014). De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: A multicenter non-blinded randomized noninferiority trial. Intensive Care Medicine. https://doi.org/10.1007/s00134-014-3411-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.